Education and Training
GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)
An observational study to evaluate the natural progression of dry AMD in genetically defined subjects
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Inclusion Criteria:
1. Adults with unilateral or bilateral Geographic Atrophy (GA) due to Age-related Macular
Degeneration (AMD)
2. BCVA of 40 letters or better using ETDRS charts
Exclusion Criteria:
1. Evidence or history of neovascular Age-related Macular Degeneration (AMD) or diabetic
retinopathy
2. Significant ocular or non-ocular disease that would impact the subject's ability to
participate in the study
3. Participation in another research study involving an investigational product within
the previous 4 weeks or 5 half-lives whichever is longer from the screening/baseline
OR received a gene/cell therapy at any time previously
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Recruiting